Pyrimidotriazole-containing LSD1 inhibitor, preparation method and application
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZHENGZHOU UNIV
- Publication Date
- 2017-07-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicinal chemistry, and specifically relates to pyrimidotriazole compounds, their preparation methods and their use in antitumor drugs targeting histone lysine specific demethylase (hereinafter referred to as LSD1) application. Background technique
[0002] Tumor is a disease that seriously endangers human health and is difficult to overcome. There are many anti-tumor drugs that have been marketed, but there are still some problems in these drugs, such as high toxicity, weak targeting, and easy drug resistance. Therefore, the research and development of new anticancer drugs is particularly important.
[0003] Histone covalent modification is an important epigenetic mode, including histone acetylation, methylation, phosphorylation, and ubiquitination, among which acetylation and methylation are more frequently studied for the mechanism of histone modification. histone modification. Before 2004, histone methylati...